Home › Skin Conditions › Texas
Skin Conditions clinical trials in Texas
8 studies for Skin Conditions are looking for participants at sites in Texas.
Cities in Texas
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Derm Texas, Dallas
- Stryde Research-Epiphany Dermatology, Southlake
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 12, 2026 · NCT07765888A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
- Arlington Research Center, Arlington
- Dermatology Treatment and Research Center, Dallas
- Derm Texas, Dallas
- and 2 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 6, 2026 · NCT07783425A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
- Dermatology Treatment and Research Center, Dallas
- Pediatric Dermatology of North Texas, Grapevine
- Texas Dermatology and Laser Specialists, San Antonio
- and 1 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Nov 4, 2026 · NCT05723198Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
- J&S Studies, Inc, College Station
- Pflugerville Dermatology Clinical Research Center, Inc. d/b/a Austin Institute for Clinical Research, Pflugerville
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Nov 4, 2026 · NCT07144852A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
- Site 114, Prosper
- Site 107, Tyler
- Site 121, Tyler
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 19, 2026 · NCT07766005(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Progressive Clinical Research, PA, San Antonio
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 8, Southlake
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.